Increased use of ketamine for the treatment of depression: Benefits and concerns
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased use of ketamine for the treatment of depression: Benefits and concerns
Authors
Keywords
Ketamine, Antidepressants, Glutamate, Treatment-resistant depression
Journal
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 104, Issue -, Pages 110060
Publisher
Elsevier BV
Online
2020-08-07
DOI
10.1016/j.pnpbp.2020.110060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘That’s the Esketamine, Baby, there’s Nothing You Can Do about It!’ An Update on Glutamatergic System in Suicidal Depression
- (2020) Domenico De Berardis et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
- (2019) Thu Ha Pham et al. PHARMACOLOGY & THERAPEUTICS
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive impairment that is induced by (R)-ketamine is abolished in NMDA GluN2D receptor subunit knockout mice
- (2019) Soichiro Ide et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)
- (2019) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo–control study
- (2019) Mu-Hong Chen et al. NEUROPSYCHOPHARMACOLOGY
- The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
- (2019) Meysam Amidfar et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression
- (2019) Jennifer L. Phillips et al. NEUROPSYCHOPHARMACOLOGY
- Recovery of cognitive functioning following abstinence from ketamine
- (2019) Wai Kwong Tang et al. ADDICTIVE BEHAVIORS
- Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study
- (2019) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms
- (2019) Taro Kato et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Other drug use does not impact cognitive impairments in chronic ketamine users
- (2018) Chenxi Zhang et al. DRUG AND ALCOHOL DEPENDENCE
- The development of glutamate-based antidepressants is taking longer than expected
- (2018) Ricardo Garay et al. DRUG DISCOVERY TODAY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- The profile of cognitive impairments in chronic ketamine users
- (2018) Xiaoyin Ke et al. PSYCHIATRY RESEARCH
- Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
- (2018) Randall L. Morrison et al. PSYCHOPHARMACOLOGY
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
- (2018) Domenico De Berardis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review
- (2018) Olivia R. Cambridge et al. PSYCHIATRY RESEARCH
- Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia
- (2018) Wan-Ju Cheng et al. SCHIZOPHRENIA RESEARCH
- A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
- (2018) Samuel T. Wilkinson et al. DRUG DISCOVERY TODAY
- Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
- (2018) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Stress and Ketamine, Bimodal Influence on Cognitive Functions
- (2018) Emil Trofimiuk et al. BEHAVIOURAL BRAIN RESEARCH
- Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
- (2017) Carmine Tomasetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
- (2017) S. E. Strasburger et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex
- (2017) Julianne D. Jett et al. NEUROSCIENCE
- Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
- (2017) Francesco Bartoli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages
- (2016) Ennio Avolio et al. MOLECULAR NEUROBIOLOGY
- The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence
- (2016) F. Ferrari et al. MOLECULAR NEUROBIOLOGY
- Ketamine Corrects Stress-Induced Cognitive Dysfunction through JAK2/STAT3 Signaling in the Orbitofrontal Cortex
- (2016) Michael S Patton et al. NEUROPSYCHOPHARMACOLOGY
- The Effects of Long-Term Ketamine Treatment on Cognitive Function in Complex Regional Pain Syndrome: A Preliminary Study
- (2016) Minseung Kim et al. PAIN MEDICINE
- Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
- (2016) Yong-Ku Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The similarities and differences in impulsivity and cognitive ability among ketamine, methadone, and non-drug users
- (2016) Hong Zeng et al. PSYCHIATRY RESEARCH
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity
- (2016) Runtao Ding et al. Scientific Reports
- Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
- (2015) Ellen E. Lee et al. GENERAL HOSPITAL PSYCHIATRY
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
- (2015) Bruno Romeo et al. PSYCHIATRY RESEARCH
- Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway
- (2015) Julianne D. Jett et al. PSYCHOPHARMACOLOGY
- Relationship Between Cognitive Impairment and Depressive Symptoms in Current Ketamine Users
- (2015) W. K. Tang et al. Journal of Studies on Alcohol and Drugs
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Repeated Administration of Ketamine can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment via the ROS/HIF-1a Pathway in Developing Rats
- (2014) Jia Yan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MAPK signaling correlates with the antidepressant effects of ketamine
- (2014) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Ketamine administration in depressive disorders: a systematic review and meta-analysis
- (2014) Guillaume Fond et al. PSYCHOPHARMACOLOGY
- Pilot dose–response trial of i.v. ketamine in treatment-resistant depression
- (2014) Rosalyn Lai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cognitive impairments in poly-drug ketamine users
- (2013) H.J. Liang et al. ADDICTIVE BEHAVIORS
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine as a new treatment for depression: A review of its efficacy and adverse effects
- (2013) Natalie Katalinic et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat
- (2013) Francois Gastambide et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Reviewing the ketamine model for schizophrenia
- (2013) Joel Frohlich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine prevents stress-induced cognitive inflexibility in rats
- (2013) Agnieszka Nikiforuk et al. PSYCHONEUROENDOCRINOLOGY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers
- (2012) Lawrence P. Carter et al. PSYCHOPHARMACOLOGY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Efficacy and Effectiveness of Antidepressants: Current Status of Research
- (2010) H. Edmund Pigott et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now